======= METAP1 ======= == Gene Information == * **Official Symbol**: METAP1 * **Official Name**: methionyl aminopeptidase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23173|23173]] * **UniProt**: [[https://www.uniprot.org/uniprot/P53582|P53582]] * **Interactions**: [[https://thebiogrid.org/search.php?search=METAP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20METAP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610151|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Cotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). Required for normal progression through the cell cycle. {ECO:0000255|HAMAP- Rule:MF_03174, ECO:0000269|PubMed:16274222, ECO:0000269|PubMed:17114291}. |Peptidase M24| |protein initiator methionine removal| |metalloexopeptidase activity| |peptidyl-methionine modification| |metalloaminopeptidase activity| |regulation of rhodopsin mediated signaling pathway| |N-terminal protein amino acid modification| |aminopeptidase activity| |platelet aggregation| |homotypic cell-cell adhesion| |platelet activation| |regulation of G protein-coupled receptor signaling pathway| |blood coagulation| |coagulation| |hemostasis| |regulation of translation| |regulation of cellular amide metabolic process| |wound healing| |regulation of body fluid levels| |cell-cell adhesion| |posttranscriptional regulation of gene expression| |response to wounding| |peptidyl-amino acid modification| |cell adhesion| |biological adhesion| |cell activation| |regulation of response to external stimulus| |proteolysis| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-3.36| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-3.32| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.24| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.99| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.82| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-1.71| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.71| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.78| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.84| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.84| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.94| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.03| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.33| |[[:results:exp287|HMS-I2 5μM R06 exp287]]|2.33| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.35| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|2.83| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|3.53| ^Gene^Correlation^ |[[:human genes:u:usp32|USP32]]|0.4| Global Fraction of Cell Lines Where Essential: 48/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|4/28| |blood|0/28| |bone|4/26| |breast|0/33| |central nervous system|3/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|1/21| |liver|1/20| |lung|3/75| |lymphocyte|0/16| |ovary|2/26| |pancreas|6/24| |peripheral nervous system|3/16| |plasma cell|0/15| |prostate|0/1| |skin|2/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|3/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4651 * **Expression level (log2 read counts)**: 6.52 {{:chemogenomics:nalm6 dist.png?nolink |}}